Skip to content

Collegium Pharmaceutical

US · COLL #3535 by market cap Listed 2015
24.72 -0.49 -1.94%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 25.06 -0.60%
After-hours 24.72 0.00%
Overnight 25.20 -0.04%
37.4721.5324.722026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on COLL?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -27.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 16.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 22.7x Better than 35%
Forward P/E 12.6x Better than 65%
Price / Sales 1.0x Better than 78%
P/E vs own 5-yr range 74th pctl Better than 34%
Growth A-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 18.9% Better than 81%
Net income CAGR (3Y) -1.1% Better than 39%
Free cash flow CAGR (3Y) 38.8% Better than 80%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 59.3% Better than 73%
Operating margin 22.9% Better than 81%
Net margin 8.1% Better than 54%
Return on equity 23.7% Better than 82%
Return on invested capital 10.1% Better than 68%
Momentum D+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -8.8% Better than 53%
6-month return -27.4% Better than 20%
12-month return (ex latest month) -49.1% Better than 3%
Distance below 52-week high 51.3% Better than 17%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 43%
Debt to assets 49.2% Better than 16%
Interest coverage 2.1x Better than 37%
Free cash flow / net income 521.0% Better than 93%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 83.3% Better than 63%
Upside to average target 84.1% Better than 79%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -2.37%
1M +6.41%
3M -10.24%
6M -27.76%
YTD -46.61%
1Y -43.75%
3Y -3.40%
5Y +31.14%

Key statistics

Price & volume

Prev close
25.21
Open
25.06
Day range
24.64 - 25.43
Avg price
24.85
Volume
528.02K
Turnover
13.12M
Amplitude
3.15%
52-week range
21.43 - 50.79

Valuation

P/E
14.29
P/E (TTM)
22.68
P/B
2.59
EPS
1.73
Net profit
53.76M
Net assets
296.43M

Share structure

Market cap
768.18M
Float cap
698.96M
Shares out
31.08M
Float shares
28.27M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2015-05-07
52-week range 11% of range
21.43 50.79

51.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-419.74K net over the window

Short interest

Shares short
5.19M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Collegium Pharmaceutical (COLL)?

Collegium Pharmaceutical last traded at 24.72. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Collegium Pharmaceutical's market cap?

About 768.18M.

What is the P/E ratio of Collegium Pharmaceutical?

The trailing twelve-month P/E is 22.68, above its own 5-year average of 11.57 — toward the top of its historical range (73.66% percentile). See the Valuation tab for the full history.

Does Collegium Pharmaceutical pay a dividend?

Collegium Pharmaceutical does not currently pay a regular dividend.

Is Collegium Pharmaceutical a buy according to analysts?

The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 45.50, which implies 84.1% upside from the current price. This is not investment advice.

What is Collegium Pharmaceutical's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Collegium Pharmaceutical a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Collegium Pharmaceutical discussion 0 comments

Add a comment